Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)

Haigan Yang, Zheshen Li, Zhuoxun Wu, Xiang Chen, Letao Bo, Harsh Patel, Bohan Zhang, Wenjun Xiong, Wei Wang, Zhe-Sheng Chen

Open source

DOI
10.3389/fphar.2025.1606857
Published
2025-06-13
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1606857,
  title = {Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)},
  author = {Haigan Yang and Zheshen Li and Zhuoxun Wu and Xiang Chen and Letao Bo and Harsh Patel and Bohan Zhang and Wenjun Xiong and Wei Wang and Zhe-Sheng Chen},
  year = {2025},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2025.1606857},
  url = {https://doi.org/10.3389/fphar.2025.1606857}
}

RIS

TY  - JOUR
TI  - Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
AU  - Haigan Yang
AU  - Zheshen Li
AU  - Zhuoxun Wu
AU  - Xiang Chen
AU  - Letao Bo
AU  - Harsh Patel
AU  - Bohan Zhang
AU  - Wenjun Xiong
AU  - Wei Wang
AU  - Zhe-Sheng Chen
PY  - 2025
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2025.1606857
UR  - https://doi.org/10.3389/fphar.2025.1606857
ER  - 

APA

Yang, H., Li, Z., Wu, Z., Chen, X., Bo, L., Patel, H., Zhang, B., Xiong, W., Wang, W., & Chen, Z. (2025). Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206). Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1606857

Source records